Ownership

John B. Henneman III - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: APRE on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

John B. Henneman III - trading volume in the past year for Aprea Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+6.86K	100%	$7.29	+$50K
Sells
Net	+6.86K	100%		+$50K

Holdings reported by John B. Henneman III for Aprea Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	9.18K	$67K	$7.29	Jun 20, 2024	Direct
Stock Options (Right to Buy)	4.19K			Jun 20, 2024	Direct	Common Stock
Tranche A Warrant	3.43K			Mar 13, 2024	Direct	Common Stock
Tranche B Warrant	3.43K			Mar 13, 2024	Direct	Common Stock

Transactions reported by John B. Henneman III for Aprea Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.